retatrutide trial weight loss data Looking forward to when #retatrutide's Phase 3 results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁

Mertz A, Nguyen NA, Katsanos KH, Kwok RM

Clin Liver Dis

Key considerations in co-occurring eating disorders and substance use include: High rates of overlap between eating disorders and substance use disorders Increased medical, nutritional, and psychological risk when conditions interact Greater vulnerability to relapse if only one condition is addressed Effective care treats both conditions simultaneously rather than in isolation

Nordisk always puts patient safety first, and we urge all stakeholders, including the FDA, Boards of Pharmacy, and law enforcement, to take decisive action to uphold the highest quality standards of care.